MedPath

Clinical Trial of the efficacy and safety of topical phenothrin lotion and ivermectin lotion for head lice infestations.

Not Applicable
Conditions
head lice infestations
Registration Number
JPRN-UMIN000016170
Lead Sponsor
Tokyo university of science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

(1)A patient who has obstacle of a barrier of skin by head skin diseases. (2)A patient who has the following disease. The disease which can have an effect on test outcome judged by a test doctor in attendance, or the disease which can have a bad effect by application of phenothrin or ivermectin. (3)A patient with the medical history which is sensitivity to the components of sumithrin lotion 5% or Sklice lotion 0.5%,other pediculicides,insecticides ,hair care goods. (4)A patient who received treatments for head lice infestations(OTC, home remedy, prescription)in the last 4 weeks. (5)A female who is pregnant, possibility of pregnancy,nursing. (6)Drugs and alcohol abuser. (7)Illegal drugs addict. (8)A patient who participated in a clinical trial in the last 4 weeks. (9)A patient who judged by a test doctor in attendance to be unsuitable as a subject.

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The percentage of patients who were not observed of head louse(regardless of life or death) after application of test drugs(cure rate).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath